D. E. Shaw & Co »

Urogen Pharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 889k 19.95
2025-06-30 $376k 27k 13.70
2024-06-30 $182k 11k 16.78
2023-12-31 $1.2M 78k 15.00
2023-09-30 $471k 34k 14.01

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma